Concepedia

Publication | Closed Access

Intermediate-Dose Melphalan (100 mg/m2)/Bortezomib/Thalidomide/Dexamethasone and Stem Cell Support in Patients with Refractory or Relapsed Myeloma

DOI

23

Citations

13

References

2006

Year

Antonio Palumbo, Ilaria Avonto, Benedetto Bruno, Antonietta Falcone, Potito Rosario Scalzulli, Maria Teresa Ambrosini, Sara Bringhen, Francesca Gay, Cecilia Rus, Federica Cavallo,
Clinical Lymphoma & Myeloma

References

YearCitations

Page 1